Cynthia Donovan, a registered New York dietitian, embarked on a pre-wedding trend followed by millions of brides, but soon ...

Amgen's late-stage weight-loss drug MariTide is getting ready to enter the final stages of testing as the company enrolls its ...

Shares of Novo Nordisk (NYSE: NVO) are tumbling on Monday, down 5.6% as of 2:11 p.m. ET. The drop comes as the S&P 500 ...

Former child star Amanda Bynes confessed that she is using Ozempic for weight loss, hoping to improve her paparazzi photos. She has openly discussed her body image issues and mental health struggles ...

Once-monthly maridebart cafraglutide resulted to significant weight loss at 1 year among adults with obesity, regardless of ...

Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly one-quarter of their body weight in early trials.

A new clinical trial found that taking a popular diabetes and weight-loss drug once weekly significantly improves blood sugar ...

Amgen's long-acting experimental obesity drug MariTide needs to be given at a low starting dose to limit side effects like vomiting, according to mid-stage trial results presented at a medical meeting ...

Amanda Bynes is going on a weight loss journey with Ozempic. The former Nickelodeon star, 39, shared a new video to her ...

The companies engaged in an increasingly heated war of words on Monday following the drugmaker's decision to end a collaboration.